SCHEMBL9707498

SCHEMBL9707498

CCc1nc2c(c(=O)[nH]c(=O)n2CC(C)C)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
AGTR1 P30556 1/20 0.44
AGTR2 P50052 1/20 0.44
ALDH1A1 P00352 4/20 0.43
THRB P10828 1/20 0.43
KDM4E B2RXH2 3/20 0.42
HPGD P15428 2/20 0.42
TPH1 P17752 10/20 0.42
TPH2 Q8IWU9 10/20 0.42
HSD17B10 Q99714 2/20 0.41
TSHR P16473 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.41
PKM P14618 1/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9708184 0.94 MEN1 (0.47) MEN1KMT2AAGTR1AGTR2ALDH1A1
SCHEMBL9707854 0.92 AGTR1 (0.48) MEN1KMT2AAGTR1AGTR2
SCHEMBL9708297 0.91 MEN1 (0.54) MEN1KMT2AAGTR1AGTR2TPH1
SCHEMBL9707363 0.91 AGTR1 (0.46) MEN1KMT2AAGTR1AGTR2
SCHEMBL9708617 0.91 MEN1 (0.42) MEN1KMT2AALDH1A1THRBKDM4E
SCHEMBL9708151 0.90 ALDH1A1 (0.46) MEN1KMT2AALDH1A1THRBKDM4E
SCHEMBL9708861 0.90 TPH1 (0.51) MEN1KMT2AAGTR1AGTR2ALDH1A1
SCHEMBL9707557 0.89 ALDH1A1 (0.43) MEN1KMT2AALDH1A1THRBKDM4E
SCHEMBL9708384 0.88 MEN1 (0.48) MEN1KMT2AAGTR1AGTR2ALDH1A1
SCHEMBL9708299 0.88 MEN1 (0.49) MEN1KMT2AAGTR1AGTR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed